Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300.
Rosales M, Pérez GV, Ramón AC, Cruz Y, Rodríguez-Ulloa A, Besada V, Ramos Y, Vázquez-Blomquist D, Caballero E, Aguilar D, González LJ, Zettl K, Wiśniewski JR, Yang K, Perera Y, Perea SE. Rosales M, et al. Among authors: vazquez blomquist d. Biomedicines. 2021 Jul 1;9(7):766. doi: 10.3390/biomedicines9070766. Biomedicines. 2021. PMID: 34356831 Free PMC article.
CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model.
Pérez GV, Rosales M, Ramón AC, Rodríguez-Ulloa A, Besada V, González LJ, Aguilar D, Vázquez-Blomquist D, Falcón V, Caballero E, Carvalho PC, Caldeira RS, Yang K, Perera Y, Perea SE. Pérez GV, et al. Among authors: vazquez blomquist d. Biomedicines. 2022 Dec 25;11(1):43. doi: 10.3390/biomedicines11010043. Biomedicines. 2022. PMID: 36672551 Free PMC article.
Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG) in patients with mycosis fungoides: an open-label trial.
García-Vega Y, García-García I, Collazo-Caballero SE, Santely-Pravia EE, Cruz-Ramírez A, Tuero-Iglesias AD, Alfonso-Alvarado C, Cabrera-Placeres M, Castro-Basart N, Duncan-Roberts Y, Carballo-Treto TI, Soto-Matos J, Izquierdo-Toledo Y, Vázquez-Blomquist D, García-Iglesias E, Bello-Rivero I. García-Vega Y, et al. BMC Pharmacol Toxicol. 2012 Dec 28;13:20. doi: 10.1186/2050-6511-13-20. BMC Pharmacol Toxicol. 2012. PMID: 23272809 Free PMC article. Clinical Trial.
17 results